Author Question: Which class of drugs would the nurse expect to be prescribed to a client who is bleeding excessively ... (Read 28 times)

CQXA · **on:** Jul 23, 2018

Which class of drugs would the nurse expect to be prescribed to a client who is bleeding excessively at a surgical site?

1. Thrombolytics
2. Antifibrinolytics
3. Anticoagulants
4. Prothrombin activators

Question 2

The nurse is planning a teaching session for a client newly diagnosed with hemophilia A. Which information should be included?

1. An extra protein is present that breaks down clots too quickly.
2. A substance that is part of the clotting process is missing.
3. The blood is missing a substance that inhibits clotting.
4. There are not enough platelets present.

kristenb95 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 2
Rationale 1: Thombolytic drugs enhance the dissolving of clots.
Rationale 2: Antifibrinolytic drugs inhibit normal removal of fibrin, resulting in a clot that remains intact longer.
Rationale 3: Anticoagulants inhibit the clotting cascade, preventing clot formation.
Rationale 4: Prothrombin activators are natural substances. There are currently no drugs based on this mechanism.
Global Rationale: Antifibrinolytic drugs inhibit normal removal of fibrin, resulting in a clot that remains intact longer. Thombolytic drugs enhance the dissolving of clots. Anticoagulants inhibit the clotting cascade, preventing clot formation. Prothrombin activators are natural substances. There are currently no drugs based on this mechanism.

Answer to Question 2

Correct Answer: 2
Rationale 1: Hemophilia is not characterized by an extra protein.
Rationale 2: Hemophilia is characterized by a missing clotting factor.
Rationale 3: The substance that is missing promotes clotting.
Rationale 4: Hemophilia does not affect platelets.
Global Rationale: Hemophilia is characterized by a missing clotting factor. The substance that is missing promotes clotting. Hemophilia is not characterized by an extra protein and does not affect platelets.